Diseases [C] » Nervous System Diseases [C10] » Central Nervous System Diseases » Brain Diseases » Cerebrovascular Disorders » Intracranial Hemorrhages
Diseases [C] » Cardiovascular Diseases [C14] » Vascular Diseases » Cerebrovascular Disorders » Intracranial Hemorrhages
Diseases [C] » Pathological Conditions, Signs and Symptoms [C23] » Pathologic Processes » Hemorrhage » Intracranial Hemorrhages
Description
Bleeding within the SKULL, including hemorrhages in the brain and the three membranes of MENINGES. The escape of blood often leads to the formation of HEMATOMA in the cranial epidural, subdural, and subarachnoid spaces. MeSH
Hierarchy View
Subtype Terms (7)
Cerebral Hemorrhage
84 drugs (64 approved, 20 experimental)
Hematoma, Subdural
15 drugs (13 approved, 2 experimental)
Intracranial Hemorrhage, Hypertensive
10 drugs (9 approved, 1 experimental)
Intracranial Hemorrhage, Traumatic
2 approved drugs
Subarachnoid Hemorrhage
98 drugs (77 approved, 21 experimental)
Phase 4 Indicated Drugs (14)
Phase 2 Indicated Drugs (4)
Phase 1 Indicated Drugs (5)
Organization Involved with Phase 4 Indications (15)
Organization Involved with Phase 3 Indications (25)
Organization Involved with Phase 2 Indications (6)
Organization Involved with Phase 1 Indications (13)
Organization Involved with Other Experimental Indications (3)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
